Clinical Research Unit, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, PR China.
Maturitas. 2019 Dec;130:50-56. doi: 10.1016/j.maturitas.2019.10.009. Epub 2019 Oct 14.
Although both age at menarche and age at menopause may independently affect the risk of cardiovascular diseases and all-cause mortality, their joint association with mortality is less clear. The objectives of this study were to address the relationship between ages at menarche and at menopause with mortality among postmenopausal women.
The study included 75,359 U.S. postmenopausal women aged 50-78 years from the Prostate, Lung, Colorectal, and Ovarian (PLCO) cohort. Information on ages at menarche and menopause was self-reported and collected at baseline, by questionnaire.
All-cause, cardiovascular and cancer mortality.
After a median follow-up of 13 years, we identified 7826 deaths among 75,359 women in the PLCO cohort. Compared with women with an age at menarche of 12-13 years and an age at menopause of 45-54 years, the adjusted hazard ratios (95% confidence interval) for all-cause mortality for women with early menarche (≤11 years) and menopause (≤44 years) and those with late menarche (≥14 years) and menopause (≥55 years) were 1.20 (1.09, 1.32) and 0.82 (0.71, 0.96), respectively. This association remained significant in a sensitivity analysis that excluded women who did not undergo natural menopause. The indexes for the additive effect of the combined association showed no excess risk due to an interaction.
Early menarche and early menopause seemed to have an exactly additive effect on all-cause mortality. The findings suggest that it is important to evaluate ages at both menarche and menopause rather than to consider either variable on its own in assessing the risk of mortality.
尽管初潮年龄和绝经年龄都可能独立影响心血管疾病和全因死亡率的风险,但它们与死亡率的联合关联尚不清楚。本研究的目的是探讨初潮年龄和绝经年龄与绝经后女性死亡率之间的关系。
本研究纳入了来自前列腺癌、肺癌、结直肠癌和卵巢癌(PLCO)队列的 75359 名年龄在 50-78 岁之间的美国绝经后女性。初潮和绝经年龄的信息由问卷调查自报,并在基线时收集。
全因、心血管和癌症死亡率。
在中位随访 13 年后,在 PLCO 队列的 75359 名女性中,我们发现了 7826 例死亡。与初潮年龄为 12-13 岁、绝经年龄为 45-54 岁的女性相比,初潮年龄早(≤11 岁)、绝经年龄早(≤44 岁)以及初潮年龄晚(≥14 岁)、绝经年龄晚(≥55 岁)的女性的全因死亡率调整后危险比(95%置信区间)分别为 1.20(1.09,1.32)和 0.82(0.71,0.96)。在排除未经历自然绝经的女性的敏感性分析中,该关联仍然显著。联合关联的附加效应指标显示,由于交互作用,没有过度风险。
初潮早和绝经早似乎对全因死亡率有确切的相加作用。这些发现表明,在评估死亡率风险时,评估初潮和绝经年龄非常重要,而不仅仅是考虑其中任何一个变量。